Zura Bio clinical trials we track

Check company identity source

Phase 2 2 trials

TrialDrugs studiedStatusPrimary completion
Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)NCT06843239TibulizumabActive not recruiting2027-05Estimated
Tibulizumab Skin Healing and Inflammation Evaluation for Lasting DefenseNCT06993610Tibulizumab Dose A, Tibulizumab Dose BActive not recruiting2026-09-18Actual

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters

· 4 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 225 participants (planned). After: 247 participants (actual).

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Nov 2026. After: 18 Sep 2026.

Check registry source